Global Home - About us - Our sites - Raleigh, NC, USA

Raleigh, NC, USA

Xellia Raleigh

Manufacturing site

At the end of February 2019 we entered into an agreement to divest our Raleigh, North Carolina manufacturing plant to Sagent Pharmaceuticals. We will continue to operate the plant for a transitional period as we gradually transition the operations of the facility to the buyer.

This strategic divestment allows us to focus investments on our two main sterile injectables facilities in Cleveland and Copenhagen and to strengthen and build new capabilities that are aligned with our innovative product portfolio.